Regulatory Approval

Regulatory Approval

Eco Animal Health Group Plc

7^th September 2015

ECO Animal Health Group plc
(AIM: EAH)

ECO RECEIVES OFFICIAL MAXIMUM RESIDUE LEVEL FOR AIVLOSIN® IN EGGS FOR THE EU

ECO is pleased to announce that it has received an official maximum residue level (MRL) for Aivlosin® (tylvalosin) for poultry eggs from the Committee for Medicinal Products for Veterinary Use at the European Medicines Agency.

This MRL will allow ECO to accelerate the development of Aivlosin® for treating poultry laying eggs for human consumption in its key global markets.

Aivlosin^®, ECO’s patented antimicrobial, is used for the treatment of a variety of economically important respiratory and enteric (gut) diseases in poultry and pigs.

Peter Lawrence, Chairman of ECO, commented “This official MRL for eggs from the European regulatory authorities is another encouraging and positive step in the development of Aivlosin® as a fast growing, truly global brand. It underlines ECO’s continued commitment to being a major force in the international market for veterinary pharmaceutical products.”

Contacts:

ECO Animal Health Group plc	Â	Â	Â	Â	Peter Lawrence	Â	Â	Â	020 8336 6190
					Marc Loomes				020 8447 8899
									Â
Spiro Financial					Anthony Spiro				020 8336 6196
									Â
Peel Hunt LLP					Dan Webster				020 7418 8900
(Nominated Adviser)
									Â

ECO Animal Health Group plc is a leader in the development, registration and marketing of pharmaceutical products for animals. Our products for these global growth markets promote well-being. Our financial goals are achieved through the careful and responsible application of science to generate value for our shareholders.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150906005037/en/